These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11760828)

  • 21. [C-reactive protein in cardiovascular risk evaluation].
    Fabijanić D; Banić M; Kardum D
    Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
    Bekpinar S; Unlüçerçi Y; Genç S; Türkmen A
    Adv Perit Dial; 2005; 21():80-4. PubMed ID: 16686291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.
    Ridker PM; Cook N
    Circulation; 2004 Apr; 109(16):1955-9. PubMed ID: 15051634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.
    Cauci S; Di Santolo M; Culhane JF; Stel G; Gonano F; Guaschino S
    Obstet Gynecol; 2008 Apr; 111(4):857-64. PubMed ID: 18378744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.
    Hueston WJ; King DE; Geesey ME
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):582-7. PubMed ID: 16268812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
    Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
    Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of C-reactive protein measurement in risk stratification during primary cardiovascular disease prevention.
    Bard RL; Rubenfire M; Eagle K; Clarke NS; Brook RD
    Am J Cardiol; 2005 Jun; 95(11):1378-9. PubMed ID: 15904650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.
    Meier-Ewert HK; Ridker PM; Rifai N; Regan MM; Price NJ; Dinges DF; Mullington JM
    J Am Coll Cardiol; 2004 Feb; 43(4):678-83. PubMed ID: 14975482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
    McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
    Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline distribution and correlation analysis of hsCRP in an insurance applicant population.
    Krause KJ; Williams DS; White N
    J Insur Med; 2008; 40(2):124-9. PubMed ID: 19119592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations?
    Sattar N; Lowe GD
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):252-6. PubMed ID: 16824274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
    Rao M; Jaber BL; Balakrishnan VS
    Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
    Ridker PM
    J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a high-sensitivity C-reactive protein assay in evaluating cardiovascular disease risk.
    Luhr TA
    Am Clin Lab; 2000; 19(9):20-1. PubMed ID: 11193978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.